Patrick Cormier

Prof. Patrick Cormier

Sorbonne University, Paris, Île-de-France, France
+2
orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2016 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
HCHéloïse Chassé
Héloïse Chassé
SBSandrine Boulben
Sandrine Boulben
VCVlad Costache
Vlad Costache
PCPatrick Cormier
Patrick Cormier
JMJulia Morales
Julia Morales
During the past decade, there has been growing interest in the role of translational regulation of gene expression in many organisms. Polysome profiling has been developed to infer the translational status of a specific mRNA species or to analyze the translatome, i.e. the subset of mRNAs actively translated in a cell. Polysome profiling is especially suitable for emergent model organisms for which genomic data are limited. In this paper, we describe an optimized protocol for the purification of sea urchin polysomes and highlight the critical steps involved in polysome purification. We applied this protocol to obtain experimental results on translational regulation of mRNAs following fertilization. Our protocol should prove useful for integrating the study of the role of translational regulation in gene regulatory networks in any biological model. In addition, we demonstrate how to carry out high-throughput processing of polysome gradient fractions, for the simultaneous screening of multiple biological conditions and large-scale preparation of samples for next-generation sequencing.

1 January 2006 in Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression
Verified
Journal Article
Closed access
FSFrédéric Le Sourd
Frédéric Le Sourd
SBSandrine Boulben
Sandrine Boulben
RBRonan Le Bouffant
Ronan Le Bouffant
PCPatrick Cormier
Patrick Cormier
JMJulia Morales
Julia Morales
OMOdile Mulner-Lorillon
Odile Mulner-Lorillon

1 December 2006 in Developmental Biology
Verified
Journal Article
Closed access
AFAntonio Fernàndez-Guerra
Antonio Fernàndez-Guerra
AAAntoine Aze
Antoine Aze
JMJulia Morales
Julia Morales
OMOdile Mulner-Lorillon
Odile Mulner-Lorillon
BCBertrand Cosson
Bertrand Cosson
AGAnne-Marie Genevière
Anne-Marie Genevière

1 September 2005 in Biochimie
Verified
Journal Article
Closed access
MBMagali Le Breton
Magali Le Breton
PCPatrick Cormier
Patrick Cormier
RBRobert Bellé
Robert Bellé
OMOdile Mulner-Lorillon
Odile Mulner-Lorillon
JMJulia Morales
Julia Morales

1 April 2001 in Developmental Biology
Verified
Journal Article
Closed access
PCPatrick Cormier
Patrick Cormier
SPStéphane Pyronnet
Stéphane Pyronnet
JMJulia Morales
Julia Morales
OMOdile Mulner-Lorillon
Odile Mulner-Lorillon
NSNahum Sonenberg
Nahum Sonenberg
RBRobert Bellé
Robert Bellé

Verified
Journal Article
Open access
PDF file
YLYasmine Lund-Ricard
Yasmine Lund-Ricard
PCPatrick Cormier
Patrick Cormier
JMJulia Morales
Julia Morales
ABAgnès BOUTET
Agnès BOUTET
A major challenge in medical research resides in controlling the molecular processes of tissue regeneration, as organ and structure damage are central to several human diseases. A survey of the literature reveals that mTOR (mechanistic/mammalian target of rapamycin) is involved in a wide range of regeneration mechanisms in the animal kingdom. More particularly, cellular processes such as growth, proliferation, and differentiation are controlled by mTOR. In addition, autophagy, stem cell maintenance or the newly described intermediate quiescence state, Galert, imply upstream monitoring by the mTOR pathway. In this review, we report the role of mTOR signaling in reparative regenerations in different tissues and body parts (e.g., axon, skeletal muscle, liver, epithelia, appendages, kidney, and whole-body), and highlight how the mTOR kinase can be viewed as a therapeutic target to boost organ repair. Studies in this area have focused on modulating the mTOR pathway in various animal models to elucidate its contribution to regeneration. The diversity of metazoan species used to identify the implication of this pathway might then serve applied medicine (in better understanding what is required for efficient treatments in human diseases) but also evolutionary biology. Indeed, species-specific differences in mTOR modulation can contain the keys to appreciate why certain regeneration processes have been lost or conserved in the animal kingdom.